Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 25, 2025 11:23 ET | Source: Research and Markets

Reflux Esophagitis (Gastroesophageal Reflux Disease) Global Clinical Trials Market Review 2025

Dublin, Nov. 25, 2025 (GLOBE NEWSWIRE) -- The "Reflux Esophagitis (Gastroesophageal Reflux Disease) - Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's...
November 24, 2025 09:18 ET | Source: Research and Markets

Artificial Intelligence (AI) in Clinical Trials Market Research Report 2025, Profiles of Major Players - IQVIA, Medidata, Saama, Merative, and Nvidia

Dublin, Nov. 24, 2025 (GLOBE NEWSWIRE) -- The "Artificial Intelligence (AI) in Clinical Trials Market" report has been added to ResearchAndMarkets.com's offering.The global market for Artificial...
November 14, 2025 05:18 ET | Source: Research and Markets

Dengue Fever Global Clinical Trials Market Review 2025 | Now Available

Dublin, Nov. 14, 2025 (GLOBE NEWSWIRE) -- The "Dengue Fever - Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.The report includes an...
November 14, 2025 05:09 ET | Source: Research and Markets

Plaque Psoriasis (Psoriasis Vulgaris) Global Clinical Trials Market Review 2025: Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status

Dublin, Nov. 14, 2025 (GLOBE NEWSWIRE) -- The "Plaque Psoriasis (Psoriasis Vulgaris) - Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.This...
November 03, 2025 06:10 ET | Source: Research and Markets

CD40 Targeted Therapies Opportunity Insights Report 2026-2027: Market is Emerging with Over 35 Therapies in Trials and is Driven by Technological Innovations and Global Collaborations

Dublin, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The "CD40 Targeted Therapies Clinical Trials, Therapeutic Approaches, Proprietary Technology Platforms & Market Opportunity Insight 2026" report has...
August 13, 2025 06:00 ET | Source: Greenwich LifeSciences, Inc.

Greenwich LifeSciences Announces Expansion of Flamingo-01 into Romania

STAFFORD, Texas, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial,...
July 22, 2025 05:17 ET | Source: Research and Markets

Endometriosis Global Clinical Trials Market Review 2025 | Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status

Dublin, July 22, 2025 (GLOBE NEWSWIRE) -- The "Endometriosis - Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial report...
May 22, 2025 09:41 ET | Source: Research and Markets

CD40 Targeted Therapies Market Research Report 2025: Clinical Trials, Therapeutic Approaches & Market Opportunities to 2027 - Competition Heats Up with 20+ Therapies in Advanced Stage

Dublin, May 22, 2025 (GLOBE NEWSWIRE) -- The "CD40 Targeted Therapies Clinical Trials, Therapeutic Approaches & Market Opportunity Insight 2025" has been added to ResearchAndMarkets.com's...
April 17, 2025 05:54 ET | Source: Research and Markets

Clinical Trial Services Research Report 2025: Oncology, Neurology, Dermatology, CVD, Laboratory, Monitoring, Recruitment, PV, Data Management - Global Forecast to 2030

Dublin, April 17, 2025 (GLOBE NEWSWIRE) -- "Clinical Trial Services Market by Type (Laboratory, Monitoring, Recruitment, PV, Data Management), Phase (I, II, III), Therapy (Oncology, Neurology,...
April 03, 2025 08:00 ET | Source: Greenwich LifeSciences, Inc.

Greenwich LifeSciences Provides Global Update on FLAMINGO-01

STAFFORD, Texas, April 03, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial,...